Steffen AC - Search Results

1

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Ståhl S, Carlsson J. Steffen AC, et al. Cancer Biother Radiopharm. 2005 Jun;20(3):239-48. doi: 10.1089/cbr.2005.20.239. Cancer Biother Radiopharm. 2005. PMID: 15989469

2

Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

Steffen AC, Orlova A, Wikman M, Nilsson FY, Ståhl S, Adams GP, Tolmachev V, Carlsson J. Steffen AC, et al. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):631-8. doi: 10.1007/s00259-005-0012-3. Epub 2006 Mar 15. Eur J Nucl Med Mol Imaging. 2006. PMID: 16538504

3

Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Nordberg E, Steffen AC, Persson M, Sundberg AL, Carlsson J, Glimelius B. Nordberg E, et al. Among authors: steffen ac. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):771-7. doi: 10.1007/s00259-005-1761-8. Epub 2005 Mar 12. Eur J Nucl Med Mol Imaging. 2005. PMID: 15765233

4

Effects of HER2-binding affibody molecules on intracellular signaling pathways.

Ekerljung L, Steffen AC, Carlsson J, Lennartsson J. Ekerljung L, et al. Among authors: steffen ac. Tumour Biol. 2006;27(4):201-10. doi: 10.1159/000093023. Epub 2006 Apr 27. Tumour Biol. 2006. PMID: 16651854

5

Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.

Steffen AC, Almqvist Y, Chyan MK, Lundqvist H, Tolmachev V, Wilbur DS, Carlsson J. Steffen AC, et al. Oncol Rep. 2007 May;17(5):1141-7. Oncol Rep. 2007. PMID: 17390057

6

Biodistribution of 211At-labeled humanized monoclonal antibody A33.

Almqvist Y, Steffen AC, Lundqvist H, Jensen H, Tolmachev V, Sundin A. Almqvist Y, et al. Among authors: steffen ac. Cancer Biother Radiopharm. 2007 Aug;22(4):480-7. doi: 10.1089/cbr.2007.349A. Cancer Biother Radiopharm. 2007. PMID: 17803442

7

Differences in radiosensitivity between three HER2 overexpressing cell lines.

Steffen AC, Göstring L, Tolmachev V, Palm S, Stenerlöw B, Carlsson J. Steffen AC, et al. Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1179-91. doi: 10.1007/s00259-007-0713-x. Epub 2008 Jan 12. Eur J Nucl Med Mol Imaging. 2008. PMID: 18193218

8

In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.

Almqvist Y, Steffen AC, Tolmachev V, Divgi CR, Sundin A. Almqvist Y, et al. Among authors: steffen ac. Nucl Med Biol. 2006 Nov;33(8):991-8. doi: 10.1016/j.nucmedbio.2006.09.003. Nucl Med Biol. 2006. PMID: 17127172

9

Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran.

Sundberg AL, Blomquist E, Carlsson J, Steffen AC, Gedda L. Sundberg AL, et al. Among authors: steffen ac. Nucl Med Biol. 2003 Apr;30(3):303-15. doi: 10.1016/s0969-8051(02)00421-3. Nucl Med Biol. 2003. PMID: 12745022

10

Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases.

Sundberg AL, Steffen AC. Sundberg AL, et al. Among authors: steffen ac. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):279-87. doi: 10.1016/j.ijrobp.2006.07.1369. Int J Radiat Oncol Biol Phys. 2007. PMID: 17189076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters